Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C

World J Gastroenterol. 2007 Jun 14;13(22):3137-40. doi: 10.3748/wjg.v13.i22.3137.

Abstract

We report a panel of severe inflammatory and vascular intraocular disorders occurring during interferon-alpha (IFN-alpha) treatment in eight hepatitis C virus (HCV)-infected patients. These events include three cases of Vogt-Koyanagi-Harada like (VKH) disease (an association of panuveitis, retinal detachment, ear and meningeal detachment and skin and hair changes), two cases of central retinal vein occlusion, one case of central retinal artery occlusion, one case of severe hypertensive retinopathy and one case of bilateral ischemic optic neuropathy with severe visual impairment. Rare as they are, such severe ophthalmological complications require a close follow-up of HCV-infected patients under IFN-alpha treatment with ophthalmological monitoring if any ocular manifestation occurs.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Eye Diseases / chemically induced*
  • Eye Diseases / diagnosis
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Middle Aged
  • Optic Neuropathy, Ischemic / chemically induced
  • Optic Neuropathy, Ischemic / diagnosis
  • Retinal Vein Occlusion / chemically induced
  • Retinal Vein Occlusion / diagnosis
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use
  • Uveomeningoencephalitic Syndrome / chemically induced
  • Uveomeningoencephalitic Syndrome / diagnosis

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Ribavirin